Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-line immune thrombocytopenia treatment pathways: steroids vs steroids + mycophenolate
2017-001171-23Phase 3Unknown
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mycophenolate mofetil in immune thrombocytopenia (ITP) (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Time from randomisation to treatment failure. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2017-001171-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001171-23.